[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]
A Multicenter, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to Treatment as Usual Among Women With Mild to Moderate Postpartum Depression
Sponsor: Iqvia Pty Ltd
Terminated
Internal company decision
Other terminated trials from Iqvia Pty Ltd
- Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome · Phase PHASE2 · Aug 2024
- Contraception · Phase PHASE3 · Jan 2024
- Post-traumatic Stress Disorder (PTSD) · Phase PHASE1 · Aug 2023
- Cancer - Solid Tumours · Phase PHASE1 · Dec 2020
More terminations from Iqvia Pty Ltd
A NA clinical study on Postpartum Depression, this trial is terminated or withdrawn. The trial is conducted by Iqvia Pty Ltd and has accumulated 11 data snapshots since 2022. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
11 versions recorded-
Mar 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Mar 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Aug 2023 — Jul 2024 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Jun 2023 — Aug 2023 [monthly]
Suspended NA
Status: Recruiting → Suspended
▶ Show 6 earlier versions
-
May 2023 — Jun 2023 [monthly]
Recruiting NA
-
Apr 2023 — May 2023 [monthly]
Recruiting NA
-
Mar 2023 — Apr 2023 [monthly]
Recruiting NA
-
Feb 2023 — Mar 2023 [monthly]
Recruiting NA
-
Dec 2022 — Feb 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Dec 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Iqvia Pty Ltd
- Woebot Health
For direct contact, visit the study record on ClinicalTrials.gov .